<DOC>
	<DOCNO>NCT01432366</DOCNO>
	<brief_summary>It assume link patient feel think medication objective measure disease activity safety .</brief_summary>
	<brief_title>Correlation Between Beliefs About Medicine Objective Measures Efficacy Safety Rheumatoid Arthritis ( RA )</brief_title>
	<detailed_description>A total 500 subject provide 80 % power test hypothesis absolute value correlation two measure ( e.g. , BMQ Necessity DAS28 ) ≤ 0.3 ( i.e. , H0 : │r│ ≤ 0.3 ) versus alternative &gt; 0.3 ( i.e. , H1 : │r │ &gt; 0.3 ) assume absolute value true correlation 0.40 . A total 500 enrol allow approximately 5 % lose analysis due lack post baseline data . The Pearson method use correlation BMQ total score Necessity DAS28 BMQ total score Concern DAS28 . The Spearman rank method use correlation BMQ total score Safety . For latter analysis , subject classify one 3 safety category : ( 1 ) No AEs , ( 2 ) Non-serious AEs , ( 3 ) Serious AEs . 95 % confidence interval correlation provide .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Patients RA stable therapy define : Etanercept : 1x50 mg/week 2x25mg/week least 1 consecutive year . Adalimumab : 1x40 mg every week least 1 consecutive year . Oral corticosteroid : stable dos ≥ 12 week baseline Methotrexate : stable dos ≥ 12 week baseline Other DMARD 's : stable dos ≥ 12 week baseline Participation clinical observational trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>